SYNOPSIS New advances in management of lung cancer with Anti-VEGF and EGFR-TKI Dr. Alan SANDLER Department of Medicine, The Vanderbilt University, USA Lung cancer is the leading cause of cancer related mortality in the - Sandler - Document - PDFSEARCH.IO

First Page	Meta Content
	SYNOPSIS New advances in management of lung cancer with Anti-VEGF and EGFR-TKI Dr. Alan SANDLER Department of Medicine, The Vanderbilt University, USA Lung cancer is the leading cause of cancer related mortality in the Add to Reading List Document Date: 2013-05-09 06:29:03 Open Document File Size: 119,97 KB Share Result on Facebook City Beijing / / Country United States / / Facility The Vanderbilt University / / MedicalCondition tumor / advanced disease / lung cancer / cancer / USA Lung cancer / non-small cell lung cancer / NSCLC / / MedicalTreatment adjuvant chemotherapy / chemotherapy / anticancer therapy / / Organization Alan SANDLER Department of Medicine / Vanderbilt University / / Product carboplatin / paclitaxel / cisplatin / / Technology chemotherapy / / SocialTag Oncology Angiology Tyrosine kinase receptors Amines Quinazolines Bevacizumab Vascular endothelial growth factor Erlotinib Angiogenesis inhibitor Medicine

SYNOPSIS New advances in management of lung cancer with Anti-VEGF and EGFR-TKI Dr. Alan SANDLER Department of Medicine, The Vanderbilt University, USA Lung cancer is the leading cause of cancer related mortality in the Add to Reading List